Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 14, 2022

BUY
$2.36 - $3.57 $36,816 - $55,692
15,600 Added 780.0%
17,600 $47,000
Q1 2018

May 15, 2018

SELL
$3.54 - $4.54 $70,800 - $90,800
-20,000 Reduced 90.91%
2,000 $7,000
Q4 2017

Feb 14, 2018

SELL
$3.23 - $4.3 $646 - $860
-200 Reduced 0.9%
22,000 $85,000
Q3 2017

Nov 14, 2017

BUY
$2.18 - $2.57 $48,396 - $57,054
22,200
22,200 $57,000

Others Institutions Holding RIGL

About RIGEL PHARMACEUTICALS INC


  • Ticker RIGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 172,836,000
  • Market Cap $2.48B
  • Description
  • Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...
More about RIGL
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.